UDP-glucuronosyltransferase activity in human liver and colon

Area of Science:

• Pharmacogenomics
• Drug Metabolism
• Molecular Biology

Background:

• UDP-glucuronosyltransferases (UGTs) are crucial for drug metabolism via glucuronidation.
• The UGT1A gene locus exhibits tissue-specific regulation, leading to varied expression in hepatic and extrahepatic tissues.
• Understanding UGT1A expression in human liver and colon is vital for predicting drug efficacy and toxicity.

Purpose of the Study:

• To investigate and compare UGT1A expression and activity in human hepatic and colonic tissues.
• To elucidate the molecular mechanisms underlying tissue-specific regulation of UGT1A isoforms.

Main Methods:

• Analysis of UGT1A messenger RNA, protein levels, and catalytic activity in liver and colon tissue samples.
• Utilized duplex reverse-transcription polymerase chain reaction (RT-PCR), Western blot, and enzymatic assays.
• Indirect immunofluorescence was employed to study protein localization.

Main Results:

• Distinct UGT1A gene expression patterns were observed between liver and colon tissues, confirmed by Western blot analysis.
• Colonic microsomal UGT activity was significantly lower (up to 96-fold) for phenolic substrates compared to hepatic activity.
• UGT activity for tertiary amines and some steroid hormones showed comparable levels between the two tissues.

Conclusions:

• Significant differences in glucuronidation activity exist between human liver and colon.
• UGT1A activity regulation is likely influenced by the presence of specific isoforms with varying catalytic efficiencies.
• Tissue-specific modulators may play a role in post-transcriptional regulation of UGT1A gene expression.